Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
(±)8(9)-DiHET is an oxylipin and a racemic mixture of the arachidonic acid metabolites 8(S),9(R)-DiHET and 8(R),9(S)-DiHET.1 It is formed from arachidonic acid (Item Nos. 90010 | 90010.1 | 10006607) via an (±)8(9)-EET (Item No. 50351) intermediate by epoxide hydrolases. (±)8(9)-DiHET (1 µM) induces cAMP production in primary human coronary artery smooth muscle cells.2 Plasma levels of (±)8(9)-DiHET are increased in a mouse model of osteoarthritic pain induced by destabilization of the medial meniscus, an effect that can be reversed by the soluble epoxide hydrolase (sEH) inhibitor TPPU (Item No. 11120).3 Spinal cord levels of (±)8(9)-DiHET are also increased in a rat model of surgically-induced acute spinal cord injury (SCI).4
WARNING This product is not for human or veterinary use.
1. Oxygenation of arachidonic acid by hepatic monooxygenases. Isolation and metabolism of four epoxide intermediates. The Journal of Biological Chemisty 257(7), 3771-3781 (1982).
2. The epoxy fatty acid pathway enhances cAMP in mammalian cells through multiple mechanisms. Prostaglandins Other Lipid Mediat. 162, 106662 (2022).
3. Clinical and preclinical evidence for roles of soluble epoxide hydrolase in osteoarthritis knee pain. Arthritis Rheumatol. 74(4), 623-633 (2022).
4. LC-
LC-